Mandate

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

April 24, 2024

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.

Episurf Medical is a Swedish, commercial stage orthopaedics company and has a broad portfolio of products based on proprietary technology addressing joint injuries. Episurf Medical’s class B share is listed on Nasdaq Stockholm.

Vinge’s team consisted of Dain Hård Nevonen, Anna Svensson and Pernilla Björklund.

Related

Vinge has advised Stockholm Exergi AB in connection with the conclusion of a permanent carbon removal agreement with Microsoft, the world’s largest to date

Vinge has advised Stockholm Exergi in connection with the conclusion of a permanent carbon removal agreement with Microsoft, covering 3.33 million tonnes of permanent carbon removals from bio-energy with carbon capture and storage (BECCS) at Värtan, Stockholm. The agreement is the world’s largest permanent carbon removal deal to date.
May 16, 2024

Vinge advises Axcel and XPartners in connection with the acquisition of Theta

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of THETA Engineering AB (”Theta”).
May 15, 2024

Vinge advises Axcel and XPartners in connection with the acquisition of Projektkompaniet

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of Projektkompaniet i Motala AB (”Projektkomapniet”).
May 15, 2024